OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. Multiple strategies have been employed maximize antibody titer, including process parameter optimization, media optimization, and the use of perfusion systems. Fine-tuning culture conditions plays a